Public health interventions to achieve hepatitis B elimination and reduce liver cancer

We're taking a multifaceted approach to achieve hepatitis B elimination in Australia. Our research projects aim to address the key goals of the World Health Organization global hepatitis B elimination program.

Hepatitis B infection affects more than 292 million people worldwide and is a major public health issue. Without timely treatment, chronic hepatitis B infection can cause death from liver damage and liver cancer, and hepatitis B is the lead cause of liver cancer and liver-related deaths worldwide.

Due to the global scale of public health impact from hepatitis B, the World Health Organization has set hepatitis B elimination targets to be achieved by 2030 to increase diagnosis, linkage to care and treatment rates for people living with hepatitis B. But there are currently major barriers to achieving these goals within Australia.